##' phase2.TTE() provides the clinical trial design solutions for two-stage
##' trials with time-to-event outcomes based on the one-sample log-rank (OSLR)
##' test. It calculates the design parameters (e.g., t1, n1, n, c1, c) using
##' optimal, minmax and admissible methods.
##'
##' @title Two-Stage Designs with TTE Outcomes Using the One-Sample Log-Rank
##' Test
##'
##' @param shape shape parameter for the baseline hazard function assuming
##'  that the failure time follows a Weibull distribution.
##' @param S0 survival probability at the fixed time point x0 under the null
##'  hypothesis (i.e, H0).
##' @param x0 a fixed time point where the survival probability is S0 under
##' the null.
##' @param hr hazard ratio, hr < 1. s1=s0^hr, where s1 is the survival
##'  probability under the alternative hypothesis (i.e., HA) and s0 is that
##'  under H0.
##' @param tf the follow-up time (restricted or unrestricted), the time period
##'  from the entry of the last patient to the end of the trial.
##' @param ta the accrual time, the time period from the entry of the first
##' patient to the entry of the last patient. defaut = NA_real_
##' @param rate a constant accrual rate if `ta` is not given. Please consider 
##' use a reasonable rate value. If the rate is too small, the function might 
##' throw an error. defaut = NA_real_
##' @param alpha type I error.
##' @param beta type II error.
##' @param prStop the lower limit of the early stopping probability under H0,
##'  with default=0.
##' @param q_value the relative importance between the maximum sample size (n)
##'  and the expected sample size under H0 (ES) when deriving the design
##'  based on the admissible method. The default is 0.5 and the range is
##'  (0, 1). The smaller q_value is, the more importance is given to ES. The
##'  greater it is, the more importance is given to n.
##' @param dfc1 the value defines the stopping criterion of the optimization
##'  process in the minmax method with smaller values lead to more iterations,
##'  default=0.001. Change is not recommended.
##' @param dfc2 the value defines the stopping criterion of the optimization
##'  process in the optimal method, smaller values lead to more iterations,
##'  default=0.001. Change is not recommended.
##' @param dfc3 the value defines the stopping criterion of the optimization
##'  process in the admissible method, smaller values lead to more iterations,
##'  default=0.001. Change is not recommended.
##' @param maxEn the maximum of the expected sample size under null, default=
##'  10000. Change is not recommended.
##' @param range the value defines how far the parameters can deviate from the
##'  last iteration in the computation of the second-stage design parameters,
##'  default=1. Change is not recommended.
##' @param lower_limit this value defines the lower limit of the possible range of r1/t1
##'  depending on the single-stage accrual rate/time, default=0.2. Change is not
##'  recommended.
##' @param upper_limit this value defines the upper limit of the possible range of r1/t1
##'  depending on the single-stage accrual rate/time, default=0.2. Change is not
##'  recommended.
##' @param c1_p this value defines the initial center in the possible range of
##' c1, default=0.25. Change is not recommended.
##' @param nbpt_p this value defines the initial number of points checked
##' within possible ranges for n, r1/t1 and c1, default=11. Change is not
##' recommended.
##' @param pascote_p this value defines how fast the possible ranges of the
##'  two-stage design parameters shrink on each iteration, default=1.26. Change
##'  is not recommended.
##' @param restricted whether using restricted (1) or unrestricted (0)
##' follow-up, default = 0.
##'
##' @return The function returns a list that includes \bold{Single_stage},
##'  \bold{Two_stage_Optimal}, \bold{Two_stage_minmax}, and
##'  \bold{Two_stage_Admissible}, etc.
##' @return \bold{Single_stage} contains the design parameters for the
##' single-stage design:
##' \itemize{
##'           \item \emph{nsignle} the required sample size for the
##'           single-stage design.\cr
##'           \item \emph{tasingle} the estimated accrual time for the single-stage
##'           design.\cr
##'          \item \emph{csingle} the critical value for the
##'          single-stage design.\cr
##'          }
##' @return \bold{Two_stage_Optimal} contains the design parameters for the
##' two-stage design based on the optimal method (i.e., minimizing ES):\cr
##' \itemize{
##'          \item \emph{n1} and \emph{n} required sample sizes in the two-stage
##'           design by the interim and final stage, respectively.\cr
##'          \item \emph{c1} and \emph{c} critical values in the two-stage
##'          design for interim and final analysis, respectively.\cr
##'          \item \emph{t1} the interim analysis time in the two-stage design.\cr
##'          \item \emph{MTSL} the maximum total study length (the sum of the accrual
##'          time and the follow-up time).\cr
##'          \item \emph{ES} the expected sample size under null in the two-stage
##'           design.\cr
##'          \item \emph{PS} the probability of early stopping under null in the
##'           two-stage design.
##'           }
##' @return \bold{Two_stage_minmax} contains the design parameters for the two-
##' stage design based on the minmax method (i.e., minimizing the total sample
##'  size, n), including the same parameters as for the optimal method.
##' @return \bold{Two_stage_Admissible} contains the design parameters for the
##'  two-stage design based on the admissible method (i.e., a "compromise"
##'  between the optimal and the minmax method), including the same parameters
##'  as for the optimal method, as well as:\cr
##'  \itemize{
##'          \item \emph{Rho} The expected loss. Between the total sample size n
##'          derived from the minmax and the optimal method, the admissible
##'          method calculates a design for each possible value of n. The design
##'          with the lowest Rho value (i.e., first row in the output) is the
##'          recommended design based on the admissible method with the
##'          specified q-value.\cr
##'          }
##'  \bold{Other outputs}:\cr
##'  \itemize{
##'          \item \emph{param} The input values to the arguments.\cr
##'          \item \emph{difn_opSg} The difference in n between the single-stage
##'           design and the optimal two-stage designs.\cr
##'          \item \emph{difn_opminmax} The difference in n between the optimal
##'          and the minmax two-stage designs.\cr
##'          \item \emph{minmax.err} 0 or 1. If minmax.err=1, optimization
##'           for the minmax method is incomplete.\cr
##'          \item \emph{optimal.err} 0 or 1. If optimal.err=1, optimization for
##'           the optimal method is incomplete.\cr
##'          \item \emph{admiss.err} 0 or 1. If admiss.err=1, optimization for
##'          a given n value in the admissible method is incomplete.\cr
##'          \item \emph{admiss.null1} 0 or 1. If admiss.null1=1, the
##'          admissible result is unavailable due to incomplete optimization
##'          with either the minmax or the optimal method.\cr
##'          \item \emph{admiss.null2} 0 or 1. If admiss.null2=1, the
##'          admissible result is unavailable as either the minmax or the
##'          optimal result is unavailable.\cr
##'          \item \emph{admiss.null3} 0 or 1. If admiss.null3=1, the admissible
##'           result is unavailable as n in the minmax result and n in the
##'           optimal result are equal.
##'           }
##'
##' @import survival
##' @export
##' @examples
##' # 1. An example when q_value=0.1, i.e, more importance is given to ES.
##' # phase2.TTE(shape=0.5, S0=0.6, x0=3, hr=0.5, tf=1, rate=5,
##' # 					 alpha=0.05, beta=0.15, q_value=0.1, prStop=0, restricted=0)
##' # $param
##' #   shape  S0  hr alpha beta rate x0 tf q_value prStop restricted
##' # 1   0.5 0.6 0.5  0.05 0.15    5  3  1     0.1      0          0
##' #
##' # $Single_stage
##' #   nsingle tasingle  csingle
##' # 1      45        9 1.644854
##' #
##' # $Two_stage_Optimal
##' #   n1     c1  n      c     t1 MTSL    ES     PS
##' # 1 29 0.1389 48 1.6159 5.7421 10.6 37.29 0.5552
##' #
##' # $Two_stage_minmax
##' #   n1     c1  n      c     t1 MTSL      ES     PS
##' # 1 34 0.1151 45 1.6391 6.7952   10 38.9831 0.5458
##' #
##' # $Two_stage_Admissible
##' #      n1      c1  n      c     t1 MTSL      ES     PS      Rho
##' # 123  29  0.0705 47 1.6232 5.7261 10.4 37.2993 0.5281 38.26937
##' # 285  28  0.0792 48 1.6171 5.5663 10.6 37.2790 0.5316 38.35110
##' # 1701 31  0.0733 46 1.6293 6.0191 10.2 37.5828 0.5292 38.42452
##' # 170  33 -0.0405 45 1.6391 6.4245 10.0 38.7692 0.4839 39.39228
##' #
##' # $difn_opSg
##' # [1] 3
##' #
##' # $difn_opminmax
##' # [1] 3
##' #
##' # $minmax.err
##' # [1] 0
##' #
##' # $optimal.err
##' # [1] 0
##' #
##' # $admiss.err
##' # [1] 0
##' #
##' # $admiss.null1
##' # [1] 0
##' #
##' # $admiss.null2
##' # [1] 0
##' #
##' # $admiss.null3
##' # [1] 0
##'
##' # 2. An example when q_value=0.75, i.e., more importance is given to n.
##' # phase2.TTE(shape=0.5, S0=0.6, x0=3, hr=0.5, tf=1, rate=5,
##' # alpha=0.05, beta=0.15, q_value=0.75, prStop=0, restricted=0)
##' # $param
##' #   shape  S0  hr alpha beta rate x0 tf q_value prStop restricted
##' # 1   0.5 0.6 0.5  0.05 0.15    5  3  1    0.75      0          0
##' #
##' # $Single_stage
##' #   nsingle tasingle  csingle
##' # 1      45        9 1.644854
##' #
##' # $Two_stage_Optimal
##' #   n1     c1  n      c     t1 MTSL    ES     PS
##' # 1 29 0.1389 48 1.6159 5.7421 10.6 37.29 0.5552
##' #
##' # $Two_stage_minmax
##' #   n1     c1  n      c     t1 MTSL      ES     PS
##' # 1 34 0.1151 45 1.6391 6.7952   10 38.9831 0.5458
##' #
##' # $Two_stage_Admissible
##' #      n1      c1  n      c     t1 MTSL      ES     PS      Rho
##' # 170  33 -0.0405 45 1.6391 6.4245 10.0 38.7692 0.4839 43.44230
##' # 1701 31  0.0733 46 1.6293 6.0191 10.2 37.5828 0.5292 43.89570
##' # 123  29  0.0705 47 1.6232 5.7261 10.4 37.2993 0.5281 44.57483
##' # 285  28  0.0792 48 1.6171 5.5663 10.6 37.2790 0.5316 45.31975
##' #
##' # $difn_opSg
##' # [1] 3
##' #
##' # $difn_opminmax
##' # [1] 3
##' #
##' # $minmax.err
##' # [1] 0
##' #
##' # $optimal.err
##' # [1] 0
##' #
##' # $admiss.err
##' # [1] 0
##' #
##' # $admiss.null1
##' # [1] 0
##' #
##' # $admiss.null2
##' # [1] 0
##' #
##' # $admiss.null3
##' # [1] 0
##' @references
##' Wu, J, Chen L, Wei J, Weiss H, Chauhan A. (2020). Two-stage phase II survival trial design. Pharmaceutical Statistics. 2020;19:214-229. https://doi.org/10.1002/pst.1983


phase2.TTE <- function(shape, S0, x0, hr, tf, ta=NA_real_, rate=NA_real_, alpha, beta, prStop=0,
											q_value=0.5, dfc1=0.001, dfc2=0.001, dfc3=0.001,
											maxEn=10000, range=1, lower_limit=0.2, upper_limit=1.2,
											c1_p=0.25, nbpt_p=11, pascote_p=1.26, restricted=0) {
  if(is.na(ta)&is.na(rate)){
    stop("Both `ta` and `rate` are NAs, should give exactly one.")
  } else if(is.na(rate)){
    return(phase2.TTE_ta(
      shape = shape,
      S0 = S0,
      x0 = x0,
      hr = hr,
      tf = tf,
      ta = ta,
      alpha = alpha,
      beta = beta,
      prStop = prStop,
      q_value = q_value,
      dfc1 = dfc1,
      dfc2 = dfc2,
      dfc3 = dfc3,
      maxEn = maxEn,
      range = range,
      r1_p1 = lower_limit,
      r1_p2 = upper_limit,
      c1_p = c1_p,
      nbpt_p = nbpt_p,
      pascote_p = pascote_p,
      restricted = restricted
    ))
  }  else if(is.na(ta)){
    return(phase2.TTE_rate(
      shape = shape,
      S0 = S0,
      x0 = x0,
      hr = hr,
      tf = tf,
      rate = rate,
      alpha = alpha,
      beta = beta,
      prStop = prStop,
      q_value = q_value,
      dfc1 = dfc1,
      dfc2 = dfc2,
      dfc3 = dfc3,
      maxEn = maxEn,
      range = range,
      t1_p1 = lower_limit,
      t1_p2 = upper_limit,
      c1_p = c1_p,
      nbpt_p = nbpt_p,
      pascote_p = pascote_p,
      restricted = restricted
    ))
  } else {
    stop("Both `ta` and `rate` are given, should give exactly one.")
  }
}
